Suppr超能文献

神经源性去甲肾上腺素对高钾诱导收缩的不同贡献取决于动脉类型。

Differential Contribution of Nerve-Derived Noradrenaline to High K-Induced Contraction Depending on Type of Artery.

作者信息

Ishida Hirotake, Saito Shin-Ya, Hishinuma Eita, Ishikawa Tomohisa

机构信息

Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka.

出版信息

Biol Pharm Bull. 2017;40(1):56-60. doi: 10.1248/bpb.b16-00590.

Abstract

High K-induced contraction of arterial smooth muscle is thought to be mediated by membrane depolarization and subsequent activation of voltage-dependent Ca channels (VDCCs). In line with this, this study found that contraction induced by 80 mM K was almost abolished by nifedipine (1 µM), a VDCC inhibitor, in isolated rat aorta, and was markedly suppressed in the iliac artery. However, nifedipine (1 µM) only partially suppressed high K-induced contraction in the tail artery. The contractions remaining in the arteries were further reduced by non-selective cation channel (NSCC) inhibitors, including 2-aminoethoxydiphenyl borate (2-APB) (100 µM), SK&F96365 (10 µM), and 3,4-dihydro-6,7-dimethoxy-α-phenyl-N,N-bis[2-(2,3,4-trimethoxyphenyl)ethyl]-1-isoquinolineacetamide hydrochloride (LOE908) (10 µM). In particular, sustained tonic contraction was nearly abolished. Prazosin (0.3 µM), an α-adrenoceptor antagonist, partially inhibited high K-induced contraction in the tail and iliac arteries, but had no effect in the aorta. Consistently, tyramine potently induced contraction in the tail and iliac arteries, but not in the aorta. Furthermore, the inhibition by prazosin and NSCC inhibitors of the high K-induced contraction in the presence of nifedipine was comparable. These results suggest that depending on the type of artery, high K-induced contraction is mediated by Ca influx not only through VDCCs but also through NSCCs, the activation of which is due to the activation of α-adrenoceptors by the released noradrenaline from sympathetic nerve terminals resulting from high K stimulation.

摘要

高钾诱导的动脉平滑肌收缩被认为是由膜去极化以及随后电压依赖性钙通道(VDCCs)的激活介导的。与此一致的是,本研究发现,在离体大鼠主动脉中,硝苯地平(1 μM)(一种VDCC抑制剂)几乎完全消除了80 mM钾诱导的收缩,并且在髂动脉中该收缩也被显著抑制。然而,硝苯地平(1 μM)仅部分抑制了尾动脉中高钾诱导的收缩。动脉中剩余的收缩通过非选择性阳离子通道(NSCC)抑制剂进一步降低,这些抑制剂包括2-氨基乙氧基二苯硼酸盐(2-APB)(100 μM)、SK&F96365(10 μM)和3,4-二氢-6,7-二甲氧基-α-苯基-N,N-双[2-(2,3,4-三甲氧基苯基)乙基]-1-异喹啉乙酰胺盐酸盐(LOE908)(10 μM)。特别是,持续性强直收缩几乎完全被消除。哌唑嗪(0.3 μM),一种α-肾上腺素能受体拮抗剂,部分抑制了尾动脉和髂动脉中高钾诱导的收缩,但对主动脉没有影响。同样,酪胺能有效地诱导尾动脉和髂动脉收缩,但对主动脉无作用。此外,在硝苯地平存在的情况下,哌唑嗪和NSCC抑制剂对高钾诱导收缩的抑制作用相当。这些结果表明,根据动脉类型的不同,高钾诱导的收缩不仅通过VDCCs而且通过NSCCs介导钙内流,NSCCs的激活是由于高钾刺激使交感神经末梢释放去甲肾上腺素激活α-肾上腺素能受体所致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验